Finland· FI-REL-REL3187

Robaxisal Forte

A methocarbamol, kombinationen, exkl. psycholeptika product containing methocarbamol + acetylsalicylic acid, registered in Finland by John Wyeth & Brother Ltd. The same ATC class is registered in 4 of our 19 countries.

ATC M03BA53

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRobaxisal ForteATCM03BA53REGISTER NO.FI-REL-REL3187PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Methocarbamol, kombinationen, exkl. psycholeptika is registered in 4 of 19 countries.

Countries holding a registration under ATC M03BA53 (methocarbamol, kombinationen, exkl. psycholeptika), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 3 of them publish a price we can compare per daily dose

Methocarbamol, kombinationen, exkl. psycholeptika · ATC M03BA53

4 / 19 countries

  • Canada
  • Finlandprice
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Methocarbamol + Acetylsalicylic acid
Manufacturer
John Wyeth & Brother Ltd
Country
Finland (FI)
ATC code
M03BA53
ATC class
Methocarbamol, Kombinationen, exkl. Psycholeptika
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methocarbamol, kombinationen, exkl. psycholeptika in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methocarbamol, kombinationen, exkl. psycholeptika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0869b74-e35b-4b04-83b2-e0896f1803f1
GET /v1/drugs/d0869b74-e35b-4b04-83b2-e0896f1803f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "8",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "metokarbamoli, yhdistelmävalmisteet",
  "ma_number": "10739",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL3187",
  "authorised_at": "1992-06-12"
}

See everything about methocarbamol, kombinationen, exkl. psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.